Alpha and Omega MedTech,(AOM) Medical Group and Subsidiaries

Alpha and Omega MedTech (AOM) Medical Group and Subsidiaries is positioned as Africa's Healthcare Innovation Company, based in uMgungundlovu, KwaZulu-Natal. Compliant with Level 1 BBEEE, South African Health Products Regulatory Autority (SAHPRA) license 00001895MD, and CSD No. MAAA1078777, AOM is also a United Nations Global Compact Listed Company. It operates under three main pillars: localizing the manufacturing of "Made in South Africa" Medical Consumables and Products, building Community Diagnostic Centers for the 40+ Million with no private health, and providing skills development and job creation for clinical researchers. Notable milestones include a R25 Million Rand Donation of 100,000 Rapid Antibody Test Kits during the height of the delta wave variant of COVID-19, the development of Point of Care Rapid Antigen Test merged with digital health tracking, and recognition as the World's First China-Africa Healthcare Innovation Platform. Founded in 2016, AOM focuses on the manufacturing industry, with its headquarters in South Africa. As of now, there is no public information available regarding the last investment and investors. AOM's commitment to healthcare innovation and its active contributions in addressing critical healthcare challenges position the company as a noteworthy player in the African healthcare landscape.